Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2007

PHARMANIAGA BERHAD

Financial Year End

31/12/2007
Quarter2
Quarterly report for the financial period ended30/06/2007
The figureshave not been audited

Attachments

pharmaniaga_bursa_0706 (2).pdf
102 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2007
30/06/2006
30/06/2007
30/06/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
300,231
251,133
556,466
501,887
2Profit/(loss) before tax
12,181
8,266
22,411
17,177
3Profit/(loss) for the period
7,217
6,084
13,710
11,813
4Profit/(loss) attributable to ordinary equity holders of the parent
6,640
5,663
12,709
10,935
5Basic earnings/(loss) per share (sen)
6.21
5.29
11.88
10.22
6Proposed/Declared dividend per share (sen)
15.00
11.50
15.00
11.50
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
2.9400
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Directors do not recommend any payment of interim dividend for the current financial period ended 30 June 2007 (2006:nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced17 Aug 2007  
CategoryFinancial Results
Reference NoPB-070815-52223